Log in to search using one of your social media accounts:


Alternative Medicine Alone Leads to Lower Cancer Survival

Cancer patients who opt for alternative therapy instead of conventional medicine significantly decrease their chances of survival, according to researchers at Yale School of Medicine. Although the popularity of alternative medicine continues to grow, a recent study published in the Journal of the National Cancer Institute found survival rates significantly reduced for those who use it as first-line therapy. Conventional cancer treatments — chemotherapy, surgery and radiation — still produce a much better chance of survival. Mesothelioma was not included in the study, but the findings are relevant to this rare and aggressive cancer as alternative treatment becomes more commonly used. “A person with cancer who choses alternative medicine is 2.5 times more likely to die than somebody who uses proven methods of treatment,” Dr. Skyler Johnson, Yale School of Medicine radiation oncologist and lead author of the study, told Asbestos.com. “When you choose alternative medicine instead of conventional, it likely will impact survival [in a negative way].” Study Does Not Include Complementary Therapy The study looked at survival rates for breast, lung, prostate and colorectal cancers, including 840 patients diagnosed from 2004-2013 who were listed in the National Cancer Database. It did not include patients who received alternative therapies alongside conventional medicine — as many mesothelioma patients do. These are often become known as compl...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Tags: acupuncture cancer Alternative medicine alternative mesothelioma treatment alternative therapy survival alternative vs conventional medicine breast cancer colon cancer Conventional cancer treatments Dr. David Gorski Dr. Skyler Johnson Source Type: news

Related Links:

LONDON (Reuters) - Bristol-Myers Squibb's immunotherapy drug Opdivo has been recommended for some patients with lung cancer by Britain's healthcare cost watchdog NICE after the drugmaker agreed a discounted price.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
This study considered 73 patients 
Source: Pediatric Blood and Cancer - Category: Cancer & Oncology Authors: Tags: RESEARCH ARTICLE Source Type: research
Date: Wednesday, 10 18, 2017; Speaker: Jorge Carrasquillo, MD Per Diem Physician Consultant, , Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan , Kettering Cancer Center, NY; Professor of Rad, ; Building: Building 10 (Clinical Center); Lipsett Amphitheater; CME Credit; Videocast Event
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Monday, 10 23, 2017; Speaker: Angelika Amon, Ph.D., Professor, David H. Koch Institute , Massachusetts Institute of Technology; Building: Building 10 (Clinical Center); Lipsett Amphitheater; CME Credit
Source: NIH Calendar of Events - Category: American Health Source Type: events
In conclusion, we have uncovered that LINC00968 could be regarded as a novel prognostic biomarker and therapeutic target in NSCLC diagnosis and treatment. This article is protected by copyright. All rights reserved
Source: Journal of Cellular Physiology - Category: Cytology Authors: Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Metallic tastes can appear for many patients on chemo
Source: The Doctors Lounge - Psychiatry - Category: Psychiatry Tags: Neurology, Nursing, Oncology, Pharmacy, Psychiatry, Nutrition, News, Source Type: news
Then new organization intends to spearhead innovations in the cure for Prostate Cancer
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
A Glendale-based charity is donating $2.7 million to Cincinnati Children ’s Hospital to create an international consortium that will collaborate on clinical trials of promising medications for children with high-risk brain tumors. This afternoon the Cure Starts Now planned to surprise Dr. Maryam Fouladi, medical director of the Brain Tumor Center at Cincinnati Childre n’s, with a check for $1.5 million, which represents the first two years of funding for the three-year grant. The check was to…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Conclusion: HOTAIR and GAS5 levels could serve as reciprocal prognostic predictors of survival and disease progression in patients with glioblastoma. This article is protected by copyright. All rights reserved
Source: Molecular Carcinogenesis - Category: Molecular Biology Authors: Tags: BRIEF COMMUNICATION Source Type: research
By Stacy Simon The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society. The cancer death rate for men and women combined fell 25% from its peak in 1991 to 2014, the most recent year for which data are available. This decline translates to more than 2.1 million deaths averted during this time period. “Cancer Statistics, 2017,” published in the American Cancer Society’s journal CA: A Cancer Journal for Clinicians, estimates the numbers of new cancer cases and deaths expected in the US this year. The estimat...
Source: American Cancer Society :: News and Features - Category: Cancer & Oncology Tags: General Information Source Type: news
More News: Acupuncture | Alternative and Complementary Therapies | Asbestosis | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Colon Cancer | Colorectal Cancer | Complementary Medicine | Databases & Libraries | Diets | Environmental Health | Food and Drug Administration (FDA) | Herbs | Homeopathy | Lung Cancer | Mesothelioma | Nutrition | Prostate Cancer | Science | Study | Websites | Yale